Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,655,240
-
Share change
-
-223,582
-
Total reported value
-
$2,940,270,320
-
Put/Call ratio
-
239%
-
Price per share
-
$119.27
-
Number of holders
-
260
-
Value change
-
-$22,676,475
-
Number of buys
-
141
-
Number of sells
-
109
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2016
As of 30 Jun 2016,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
260 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,655,240 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Fund Advisors, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Knott David M, FMR LLC, OAK RIDGE INVESTMENTS LLC, RS INVESTMENT MANAGEMENT CO LLC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, and CARDINAL CAPITAL MANAGEMENT LLC /CT.
This page lists
260
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.